immunotherapy

BOSTON, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of…

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy…

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists in the…

Stereotactic ablative radiotherapy (SABR) combined with immunotherapy (I-SABR)…

Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab…

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported the…

Cancer immunotherapy has brought major improvement in patient survival and quality of life, especially with the success of adoptive T cell and immune checkpoint inhibitor therapies.…

New clinical research unveiled at the recent American Society of Clinical Oncology (ASCO)…

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a…

 Data highlights the differentiated mechanism of action of soquelitinib to enhance anti-tumor immune response to hematologic and solid tumorsSoquelitinib shown to increase infiltration of…